14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 300529.SZ
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Jafron Biomedical Co Ltd stock after losing 1.55%
(Updated on May 08, 2024)

Buy or Hold candidate since Apr 25, 2024 Gain 22.92% PDF

The Jafron Biomedical Co Ltd stock price fell by -1.55% on the last day (Wednesday, 8th May 2024) from ¥29.09 to ¥28.64. During the last trading day the stock fluctuated 8.83% from a day low at ¥26.83 to a day high of ¥29.20. The price has risen in 7 of the last 10 days and is up by 29.24% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -895 thousand shares and in total, 11 million shares were bought and sold for approximately ¥301.73 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at ¥29.62 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 23.83% during the next 3 months and, with a 90% probability hold a price between ¥28.75 and ¥36.68 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

300529.SZ Signals & Forecast

The Jafron Biomedical Co Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ¥27.32 and ¥23.76. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, May 06, 2024, and so far it has fallen -2.62%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Monday, April 22, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Monday, April 22, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Jafron Biomedical Co Ltd stock

Jafron Biomedical Co Ltd finds support from accumulated volume at ¥27.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved ¥2.37 between high and low, or 8.83%. For the last week, the stock has had daily average volatility of 10.73%.

The Jafron Biomedical Co Ltd stock is overbought on RSI14 and the RSI has been falling for the last couple of days. This together with the fact that the stock is in the upper part of the trend poses a possible good selling opportunity for the short-term trader. However, one should note that some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: ¥27.39 (-4.36%) (This stock has high daily movements and this gives high risk. The RSI14 is 79 and this increases the risk substantially. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (300529.SZ) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect Jafron Biomedical Co Ltd to open at ¥28.22, and during the day (based on 14 day Average True Range), to move between ¥26.80 and ¥30.48, which gives a possible trading interval of +/-¥1.84 (+/-6.41%) up or down from last closing price. If Jafron Biomedical Co Ltd takes out the full calculated possible swing range there will be an estimated 12.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at ¥29.09 (1.57%) than the support at ¥27.54 (3.84%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Jafron Biomedical Co Ltd stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Jafron Biomedical Co Ltd stock to perform well in the short-term.

Current score: 2.398 Buy Candidate Unchanged

Predicted Opening Price for Jafron Biomedical Co Ltd of Thursday, May 9, 2024

Fair opening price May 9, 2024 Current price
¥28.22 ( 1.45%) ¥28.64

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 300529.SZ

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 30.59 6.82 %
R2 29.69 3.66 %
R1 29.13 1.71 %
Current price: 28.64
Support S1 27.32 -4.62 %
S2 26.76 -6.57 %
S3 25.85 -9.73 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 29.41 2.69 %
R1 29.09 1.57 %
Current price 28.64
Support S1 27.54 -3.84%
S2 27.10 -5.38%
S3 26.15 -8.69%

300529 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 31, 2023 May 31, 2023 May 31, 2023 ¥0.670 2.42%
2 Jun 10, 2022 Jun 10, 2022 Jun 10, 2022 ¥0.90 1.94%
3 May 12, 2021 May 12, 2021 May 12, 2021 ¥0.660 0.694%
4 May 20, 2020 May 20, 2020 May 20, 2020 ¥0.474 0.777%
5 May 13, 2019 May 13, 2019 May 13, 2019 ¥0.316 0.97%

FAQ

What is the symbol for Jafron Biomedical Co Ltd Stock and on which exchange is it traded?
The symbol for Jafron Biomedical Co Ltd is 300529.SZ and it is traded on the SZCE (Shenzhen Stock Exchange).

Should I buy or sell Jafron Biomedical Co Ltd Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Jafron Biomedical Co Ltd stock to perform well in the short-term.

How to buy Jafron Biomedical Co Ltd Stock?
Jafron Biomedical Co Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jafron Biomedical Co Ltd Stock.

What's the current price of Jafron Biomedical Co Ltd Stock?
As of the end of day on the May 08, 2024, the price of an Jafron Biomedical Co Ltd (300529.SZ) share was ¥28.64.

What is the 52-week high and low for Jafron Biomedical Co Ltd Stock?
The 52-week high for Jafron Biomedical Co Ltd Stock is ¥184.48 and the 52-week low is ¥118.52.

What is the market capitalization of Jafron Biomedical Co Ltd Stock?
As of the May 08, 2024, the market capitalization of Jafron Biomedical Co Ltd is 23.692B.

When is the next earnings date for Jafron Biomedical Co Ltd?
The upcoming earnings date for Jafron Biomedical Co Ltd is May 20, 2025.
Click to get the best stock tips daily for free!

About Jafron Biomedical Co Ltd

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and ... 300529.SZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT